Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1053-1061

  Nückel, Holger ^a   Hüttmann, Andreas ^a   Klein Hitpass, Ludger ^a   Schroers, Roland ^b   Führer, Anja ^a   Sellmann, Ludger ^a   Dührsen, Ulrich ^a   Dürig, Jan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

ADAM29; B cell chronic lymphocytic leukemia (B CLL); CD38 antigen; LPL; Prognostic marker; Protein tyrosine kinase ZAP 70

Indexed keywords

CD38 ANTIGEN; DISINTEGRIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PROTEIN ADAM29; PROTEIN KINASE ZAP 70; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; B CELL LEUKEMIA; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ADAM PROTEINS; ADULT; AGED; ANTIGENS, CD38; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; PROGNOSIS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33746304485     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500464161     Document Type: Article

References (26)

1. Keating, M and Chiorazzi, N and Messmer, B and Damle, R and Allen, S and Rai, K and et al. (2003) Biology and treatment of chronic lymphocytic leukemia Hematology (Am Soc Hematol Educ Program), pp. 153-175.
2. Shanafelt, T and Geyer, S and Kay, N. (2004) Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL Blood, 103, pp. 1202-1210.
3. Hamblin, T and Davis, Z and Gardiner, A and Oscier, D and Stevenson, F. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood, 94, pp. 1848-1854.
4. Damle, R and Wasil, T and Fais, F and Ghiotto, F and Valetto, A and Allen, S and et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood, 94, pp. 1840-1847.
5. Klein, U and Tu, Y and Stolovitzky, G and Mattioli, M and Cattoretti, G and Husson, H and et al. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells J Exp Med, 194, pp. 1625-1638.
6. Rosenwald, A and Alizadeh, A and Widhopf, G and Simon, R and Davis, R and Yu, X and et al. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia J Exp Med, 194, pp. 1639-1647.
7. Wiestner, A and Rosenwald, A and Barry, T and Wright, G and Davis, R and Henrickson, S and et al. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood, 101, pp. 4944-4951.
8. Chen, L and Widhopf, G and Huynh, L and Rassenti, L and Rai, K and Weiss, A and et al. (2002) Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia Blood, 100, pp. 4609-4614.
9. Chen, L and Apgar, J and Huynh, L and Dicker, F and Giago-McGahan, T and Rassenti, L and et al. (2005) ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia Blood, 105, pp. 2036-2041.
10. Dürig, J and Naschar, M and Schmücker, U and Renzing-Köhler, K and Hölter, T and Hüttmann, A and et al. (2002) CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia Leukemia, 16, pp. 30-35.
11. Dürig, J and Nückel, H and Hüttmann, A and Kruse, E and Hölter, T and Halfmeyer, K and et al. (2003) Expression of ribosomal and translation-associated genes is correlated with a favourable clinical course in chronic lymphocytic leukemia Blood, 101, pp. 2748-2755.
12. Heintel, D and Kienle, D and Shehata, M and Kröber, A and Kroemer, E and Schwarzinger, I and (2005) High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia Leukemia, 19, pp. 1216-1223.
13. Oppezzo, P and Vasconcelos, Y and Settegrana, C and Jeannel, D and Vuillier, F and Legarff-Tavernier, M and et al. (2005) The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia Blood, 106, pp. 650-657.
14. Mead, J and Irvine, S and Ramji, D. (2002) Lipoprotein lipase: structure, function, regulation, and role in disease J Mol Med, 80, pp. 753-769.
15. Preiss-Landl, K and Zimmermann, R and Hammerle, G and Zechner, R. (2002) Lipoprotein lipase: The regulation of tissue specific expression and its role in lipid and energy metabolism Curr Opin Lipidol, 13, pp. 471-481.
16. Primakoff, P and Myles, D. (2000) The ADAM gene family: Surface proteins with adhesion and protease activity Trends Genet, 16, pp. 83-87.
17. Xu, R and Cai, J and Xu, T and Zhou, W and Ying, B and Deng, K and et al. (1999) Molecular cloning and mapping of a novel ADAM gene (ADAM29) to human chromosome 4 Genomics, 62, pp. 537-539.
18. Cerretti, D and DuBose, R and Black, R and Nelson, N. (1999) Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression Biochem Biophys Res Commun, 263, pp. 810-815.
19. Dürig J and Nückel, H and Cremer, M and Führer, A and Halfmeyer, K and Fandrey, J and et al. (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia Leukemia, 17, pp. 2426-2434.
20. Heintel, D and Kroemer, E and Kienle, D and Schwarzinger, I and Gleiss, A and Schwarzmeier, J and et al. (2004) High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia Leukemia, 18, pp. 756-762.
21. Crespo, M and Bosch, F and Villamor, N and Bellosillo, B and Colomer, D and Rozman, M and et al. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med, 348, pp. 1764-1775.
22. Schroers, R and Griesinger, F and Trümper, L and Haase, D and Kulle, B and Klein-Hitpass, L and et al. (2005) Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia Leukemia, 19, pp. 750-758.
23. Metz, C. (1978) Basic principles of ROC analysis Semin Nucl Med, 8, pp. 283-298.
24. Bland, J and Altman, D. (1998) Survival probabilities (the Kaplan-Meier method) BMJ, 317, pp. 1572.
25. Kröber, A and Seiler, T and Benner, A and Bullinger, L and Bruckle, E and Lichter, P and et al. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Blood, 100, pp. 1410-1416.
26. Hamblin, T and Orchard, J and Ibbotson, R and Davis, Z and Thomas, P and Stevenson, F and et al. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease Blood, 99, pp. 1023-1029.